Cargando…

HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens

Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein scaffold based on the HIV p24 CA protein is a highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tagliamonte, Maria, Marasco, Daniela, Ruggiero, Alessia, De Stradis, Angelo, Tornesello, Maria Lina, Totrov, Maxim, Buonaguro, Franco Maria, Buonaguro, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422313/ https://www.ncbi.nlm.nih.gov/pubmed/22912852 http://dx.doi.org/10.1371/journal.pone.0043318

Ejemplares similares

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
por: Manolio, Carmen, et al.
Publicado: (2022)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
por: Buonaguro, Franco Maria, et al.
Publicado: (2015)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
por: Visciano, M, et al.
Publicado: (2009)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

HPV monitoring in kidney transplanted patients
por: Buonaguro, Franco M, et al.
Publicado: (2012)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation
por: Buonaguro, Luigi, et al.
Publicado: (2008)

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
por: Aricò, Eleonora, et al.
Publicado: (2005)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
por: Naderi, HR, et al.
Publicado: (2006)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
por: Tornesello, Maria Lina, et al.
Publicado: (2016)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
por: Starita, Noemy, et al.
Publicado: (2018)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
por: Cerasuolo, Andrea, et al.
Publicado: (2020)

Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy
por: Tornesello, Maria Lina, et al.
Publicado: (2014)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
por: Visciano, Maria Luisa, et al.
Publicado: (2013)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
por: Tornesello, Maria Lina, et al.
Publicado: (2013)

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022)

Functional characterization of biodegradable nanoparticles as antigen delivery system
por: Petrizzo, A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lkbv39htq6925ejgrlor6uccvp